These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30220049)

  • 41. Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example.
    Mahasenan KV; Li C
    J Chem Inf Model; 2012 May; 52(5):1345-55. PubMed ID: 22540736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FLAP: GRID molecular interaction fields in virtual screening. validation using the DUD data set.
    Cross S; Baroni M; Carosati E; Benedetti P; Clementi S
    J Chem Inf Model; 2010 Aug; 50(8):1442-50. PubMed ID: 20690627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combining molecular dynamics simulation and ligand-receptor contacts analysis as a new approach for pharmacophore modeling: beta-secretase 1 and check point kinase 1 as case studies.
    Hatmal MM; Jaber S; Taha MO
    J Comput Aided Mol Des; 2016 Dec; 30(12):1149-1163. PubMed ID: 27722817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products.
    Gao Q; Wang Y; Hou J; Yao Q; Zhang J
    J Comput Aided Mol Des; 2017 Jul; 31(7):625-641. PubMed ID: 28623487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Truly Target-Focused Pharmacophore Modeling: A Novel Tool for Mapping Intermolecular Surfaces.
    Mortier J; Dhakal P; Volkamer A
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30082611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring.
    Radestock S; Weil T; Renner S
    J Chem Inf Model; 2008 May; 48(5):1104-17. PubMed ID: 18442221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screening.
    Steindl TM; Schuster D; Wolber G; Laggner C; Langer T
    J Comput Aided Mol Des; 2006 Dec; 20(12):703-15. PubMed ID: 17009092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Revisiting de novo drug design: receptor based pharmacophore screening.
    Amaravadhi H; Baek K; Yoon HS
    Curr Top Med Chem; 2014; 14(16):1890-8. PubMed ID: 25262804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimization of compound ranking for structure-based virtual ligand screening using an established FRED-Surflex consensus approach.
    Du J; Bleylevens IW; Bitorina AV; Wichapong K; Nicolaes GA
    Chem Biol Drug Des; 2014 Jan; 83(1):37-51. PubMed ID: 23941463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Consensus scoring criteria for improving enrichment in virtual screening.
    Yang JM; Chen YF; Shen TW; Kristal BS; Hsu DF
    J Chem Inf Model; 2005; 45(4):1134-46. PubMed ID: 16045308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The ensemble performance index: an improved measure for assessing ensemble pose prediction performance.
    Korb O; McCabe P; Cole J
    J Chem Inf Model; 2011 Nov; 51(11):2915-9. PubMed ID: 21962010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improving binding mode and binding affinity predictions of docking by ligand-based search of protein conformations: evaluation in D3R grand challenge 2015.
    Xu X; Yan C; Zou X
    J Comput Aided Mol Des; 2017 Aug; 31(8):689-699. PubMed ID: 28668990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel and efficient ligand-based virtual screening approach using the HWZ scoring function and an enhanced shape-density model.
    Hamza A; Wei NN; Hao C; Xiu Z; Zhan CG
    J Biomol Struct Dyn; 2013; 31(11):1236-50. PubMed ID: 23140256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. From activity cliffs to target-specific scoring models and pharmacophore hypotheses.
    Seebeck B; Wagener M; Rarey M
    ChemMedChem; 2011 Sep; 6(9):1630-9, 1533. PubMed ID: 21751401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Development of Target-Specific Pose Filter Ensembles To Boost Ligand Enrichment for Structure-Based Virtual Screening.
    Xia J; Hsieh JH; Hu H; Wu S; Wang XS
    J Chem Inf Model; 2017 Jun; 57(6):1414-1425. PubMed ID: 28511009
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling.
    Meslamani J; Li J; Sutter J; Stevens A; Bertrand HO; Rognan D
    J Chem Inf Model; 2012 Apr; 52(4):943-55. PubMed ID: 22480372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential and limitations of ensemble docking.
    Korb O; Olsson TS; Bowden SJ; Hall RJ; Verdonk ML; Liebeschuetz JW; Cole JC
    J Chem Inf Model; 2012 May; 52(5):1262-74. PubMed ID: 22482774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ligand-based and e-pharmacophore modeling, 3D-QSAR and hierarchical virtual screening to identify dual inhibitors of spleen tyrosine kinase (Syk) and janus kinase 3 (JAK3).
    Kaur M; Silakari O
    J Biomol Struct Dyn; 2017 Nov; 35(14):3043-3060. PubMed ID: 27678281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacophore based drug design approach as a practical process in drug discovery.
    Gao Q; Yang L; Zhu Y
    Curr Comput Aided Drug Des; 2010 Mar; 6(1):37-49. PubMed ID: 20370694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.